Vildagliptin

dipeptidylpeptidase 4 ; Rattus norvegicus







65 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33388732 Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin. 2021 Feb 1
2 33416077 Effects of 22 traditional anti-diabetic medicinal plants on DPP-IV enzyme activity and glucose homeostasis in high-fat fed obese diabetic rats. 2021 Jan 29 1
3 33595798 Protective roles of thymoquinone and vildagliptin in manganese-induced nephrotoxicity in adult albino rats. 2021 Jun 2
4 34277963 Dynamics of total volume of pancreatic α- and β -cells under the influence sulfonylureas and their combination with dipeptidyl peptidase-4 inhibitors. 2021 Jul 1
5 34522267 Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats. 2021 1
6 32102588 Renoprotective effect of vildagliptin following hepatic ischemia/reperfusion injury. 2020 Nov 1
7 33035520 Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways. 2020 Dec 15 1
8 30530814 Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases. 2019 Mar 2
9 30880253 A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats. 2019 Apr 1
10 31097424 Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline-Containing Thiol Adducts Formed via Cysteine or Glutathione Conjugation. 2019 Aug 2
11 31125595 Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on improving brain function in orchiectomized obese rats. 2019 Aug 1
12 29073562 Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance. 2018 Jan 1
13 29472575 Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain. 2018 Feb 22 1
14 29606326 Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats. 2018 Oct 2
15 29793329 FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats. 2018 Jan 1
16 29805536 Vildagliptin, a DPP4 inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat hippocampus. 2018 Jun 2
17 29951533 A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3. 2018 2
18 30022232 Neuroprotective effect of vildagliptin against cerebral ischemia in rats. 2018 Oct 1
19 30333575 Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats. 2018 Oct 17 1
20 30405876 Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway. 2018 1
21 28251104 Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study. 2017 Jan-Mar 1
22 28281660 DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats. 2017 Mar 10 2
23 28807765 SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. 2017 Oct 15 1
24 29036231 Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats. 2017 1
25 26632647 The protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity. 2016 Mar 3
26 27044778 Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. 2016 Jun 1
27 27326818 Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats. 2016 Aug 1
28 27462276 Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure. 2016 1
29 27543302 Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats. 2016 Oct 1
30 27723572 Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes. 2016 Dec 1
31 25588850 Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats. 2015 Apr 3
32 25752913 Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. 2015 Jun 2
33 25823534 Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction. 2015 Jun 1
34 26016746 Dipeptidyl peptidase 4 inhibitor improves brain insulin sensitivity, but fails to prevent cognitive impairment in orchiectomy obese rats. 2015 Aug 1
35 26259714 Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats. 2015 Aug 11 1
36 26382939 Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia. 2015 Dec 1 2
37 26607467 Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. 2015 Dec 15 1
38 24066937 Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in zucker diabetic fatty rat. 2014 1
39 24357666 Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart. 2014 Mar 1
40 24521405 Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats. 2014 Feb 13 2
41 23240760 DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. 2013 Mar 1
42 23364453 Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. 2013 May 1
43 23523961 Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. 2013 Apr 1
44 23591914 DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. 2013 Jul 1
45 23774700 The effects of dipeptidyl-peptidase-IV inhibitor, vildagliptin, on the exocrine pancreas in spontaneously diabetic Goto-Kakizaki rats. 2013 Jul 1
46 24081217 Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats. 2013 1
47 24117480 Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease. 2013 Dec 1
48 24148218 Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. 2013 Oct 22 2
49 22025647 Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. 2012 Feb 1
50 22155545 Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: effects of DPP-IV inhibitor vildagliptin. 2012 Apr 11 1